- Thursday, October 29, 2026
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Viral Clearance Market By Method (Viral Removal and Viral Inactivation), By Application (Recombinant Proteins, Blood & Blood Products, Vaccines, and Other Applications), By End-User (Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Other End Users), and By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa)-Global Forecast to 2027.
Global Viral Clearance Market Overview:
The biopharmaceutical industries highly adapt a Viral Clearance to remove viral contamination using chromatography or specialized membranes. The ultimate goal of viral clearance in the healthcare field is to ensure that therapeutic drugs derived from specific sources are getting rid of any viral contamination; these protein solutions undergo viral clearance to inactivate or remove viral materials. Viral clearance is essential in developing monoclonal antibodies, glycoproteins & recombinant proteins, blood & tissue-derived products, and medical devices. Viral clearance can be performed by several methods depending on product type or technique for production, such as PCR, qRT-PCR, western blotting, and ELISA.
Global Viral Clearance Market Insights
The global viral clearance market size was valued at USD 449.2 million in 2019 and projected to reach USD 1059.78 million by 2027, growing at a CAGR of 12.21% during the forecast period, 2020-2027. The major factors are the growing demand for viral clearance by the biopharmaceutical industries to manufacture therapeutics and biologics. The increasing clinical usage of viral clearance in pharmacology to protect cell culture processes, raw materials, bioreactor contamination, and downstream processing will propel the demand for viral clearance over the coming years. Additionally, the increasing utilization of viral clearance to remove virus at an early stage of drug development and increase R&D investments will spur the global viral clearance industry in the future periods. Furthermore, the growing public-private funding for novel drug development activities and rising advances in nanofiltration technology are expected to witness remarkable growth of the viral clearance industry.
Moreover, the increasing demand for new drug launches positively impacts the market for viral clearance in the healthcare industry. Furthermore, the rapidly expanding customer base, rise in the extensive R&D activities at the academic and industrial level, and increasing scope of biomedical applications are fueling the demand for the viral clearance market. The growing demand for virus inactivation and increasing demand for biopharmaceutical products & vaccines to treat numerous chronic diseases will bolster the growth of the global viral clearance market share. Additionally, the growing geriatric population and increasing healthcare infrastructure in the developing world propelling the revenue of the viral clearance market across the globe.
Growth Driver
Growing demand for viral clearance in manufacturing of biologics.
Viral clearance is used to maintain the high standard of purity in biopharmaceutics, including cell- & gene-based therapeutic products, plasma products, recombinant protein therapeutics, and vaccines, which can effectively reduce the risk of contamination and prevention of drug failures. Traditionally, In-vitro methods have been used to test the presence of contaminating viruses in the product stream. Moreover, next-generation sequencing (NGS) holds great promise in the quick and accurate detection of known and unknown contaminating viruses due to the advent of technology. It allows sensitive and specific testing of a wide range of viral contaminants instead of detecting only specific viruses allowed by current methods. However, the high cost associated with the viral removal techniques can be a restraint to the growth of the viral clearance market.
Method Segmental Analysis
Based on the method, the global viral clearance market is categorized into viral removal and viral inactivation. Furthermore, the viral removal method is sub-segmented into chromatography, nanofiltration, and precipitation. The viral inactivation is further sub-segmented into low PH, solvent detergent method, pasteurization, and other viral inactivation. The viral removal segment held for a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to the availability of advanced filtration technology with large adaptation by the biopharmaceutical& food industries, effective in the downstairs purification process, and easy removal of large viruses through filters.
The viral inactivation segment is poised to witness significant growth over the forecast period as it is relatively simple, robust, and effective against the enveloped virus.
Application Segmental Analysis
The global viral clearance market is added into recombinant proteins, blood, vaccines, and other applications based on the application. The segment’s revenue is primarily attributed to the rising demand for antiviral vaccines, rising prevalence of infectious diseases, and increasing demand for the detection of viral contaminants to innovate novel drugs &vaccines. The vaccines are expected to be the highest revenue share for viral clearance during the forecast period.
The Recombinant Protein will witness a lucrative growth rate in the estimated period due to rising research on the ground of proteomics and increasing demand for protein therapeutics.
End-User Segmental Analysis
Based on the end-user, the global viral clearance market is segmented into pharmaceutical and biotechnology companies, academic research institutes, contract research organizations, and other end users.
The pharmaceutical & biotechnology companies segment will dominate the global viral clearance market by 2027. It is due to the rising demand for biopharmaceuticals to treat chronic illnesses such as cancer and diabetes, increasing investments in drug development activities, and increasing use of viral clearance methods in the clinical trial setting.
The CROs accounted for the largest share of the viral clearance market in 2019 because of the rising demand for viral clearance studies by the biopharmaceutical industries for their biological drugs and the increasing demand for pharmaceutical purification services.
Region Segmental Analysis
The global viral clearance market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa by geography. North America is estimated to project considerable growth over 2020-2026. It is due to the rise in the number of drug launches, the growing incidence of chronic illness, and leading industry players offering innovative products.
The Asia Pacific will produce a prominent share of the viral clearance market by 2027. Due to the increasing awareness towards the health and safety of medicinal treatments, we are continually improving healthcare infrastructure in the region and mounting health care expenditures in developing countries such as India and China.
Competitor Analysis
Merck KGaA, Charles River Laboratories International, Texcell, Wuxi Biologics, Lonza Group, Kedrion, Vironova Biosafety, BslBioservice, and Virusure GmbH are the key players in the global viral clearance market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global viral clearance products manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to viral clearance
- Regulatory bodies
- Suppliers
- Retailers
The objective of the research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps assess potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines an in-depth scenario of the target market by grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics.
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs, wants, and cultural characteristics that can specifically target.
Market Modelling
By Method
- Viral Removal
- Viral Inactivation
By Application
- Recombinant Proteins
- Blood & Blood Products
- Vaccines
- Other Applications
By End-User
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Other End Users
By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Global Viral Clearance Market
Report Content
- Research Strategic Development
- Market Modelling
- Product Analysis
- Market Trend and Economic Factors Analysis
- Market Segmental Analysis
- Geographical Mapping
- Country Wise Segregation
- Research Methodology
- Identification of Target Market
- Data Acquisition
- Refining of Data/ Data Transformations
- Data Validation through Primary Techniques
- Exploratory Data Analysis
- Graphical Techniques/Analysis
- Quantitative Techniques/Analysis
- Visual Result/Presentation
- Executive Summary
- Market Insights
- Supply Chain Analysis
- Economic Factor Analysis
- Drivers
- Trends
- Opportunities
- Challenges
- Technological Landscape
- Competitors & Product Analysis
- Regulatory Framework
- Company market share analysis, 2019
- Porter’s Five forces analysis
- New Investment Analysis
- PESTEL Analysis
- Global Viral Clearance Market Overview
- Market Size & Forecast,2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Market Share & Forecast, 2016-2027
- By Method
- Viral Removal
- Viral Inactivation
- By Application
- Recombinant Proteins
- Blood & Blood Products
- Vaccines
- Other Applications
- By End-user
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Other End Users
- By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
- By Method
- Market Size & Forecast,2016-2027
- North America Viral Clearance Market Overview
- North America Viral Clearance Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- North America Viral Clearance Market Share & Forecast,2016-2027
- By Method
- Viral Removal
- Viral Inactivation
- By Application
- Recombinant Proteins
- Blood & Blood Products
- Vaccines
- Other Applications
- By End-user
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Other End Users
- By Country
- US
- Canada
- Mexico
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on North America Viral Clearance Market
- By Method
- North America Viral Clearance Market Size & Forecast, 2016-2027
- Europe Viral Clearance Market Overview
- Europe Viral Clearance Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Europe Viral Clearance Market Share & Forecast,2016-2027
- By Method
- Viral Removal
- Viral Inactivation
- By Application
- Recombinant Proteins
- Blood & Blood Products
- Vaccines
- Other Applications
- By End-user
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Other End Users
- By Country
- Germany
- UK
- France
- Italy
- Rest of Europe
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Europe Viral Clearance Market
- By Method
- Europe Viral Clearance Market Size & Forecast, 2016-2027
- Asia Pacific Viral Clearance Market Overview
- Asia Pacific Viral Clearance Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Asia Pacific Viral Clearance Market Share & Forecast, 2016-2027
- By Method
- Viral Removal
- Viral Inactivation
- By Application
- Recombinant Proteins
- Blood & Blood Products
- Vaccines
- Other Applications
- By End-user
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Other End Users
- By Country
- China
- India
- Japan
- Australia
- Rest of Asia Pacific
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Asia Pacific Viral Clearance Market
- By Method
- Asia Pacific Viral Clearance Market Size & Forecast, 2016-2027
- South America Viral Clearance Market Overview
- South America Viral Clearance Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- South America Viral Clearance Market Share & Forecast,2016-2027
- By Method
- Viral Removal
- Viral Inactivation
- By Application
- Recombinant Proteins
- Blood & Blood Products
- Vaccines
- Other Applications
- By End-user
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Other End Users
- By Country
- Brazil
- Argentina
- Rest of South America
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on South America Viral Clearance Market
- By Method
- South America Viral Clearance Market Size & Forecast, 2016-2027
- Middle East & Africa Viral Clearance Market Overview
- Middle East & Africa Viral Clearance Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Middle East & Africa Viral Clearance Market Share & Forecast, 2016-2027
- By Method
- Viral Removal
- Viral Inactivation
- By Application
- Recombinant Proteins
- Blood & Blood Products
- Vaccines
- Other Applications
- By End-user
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Other End Users
- By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Middle East & Africa Viral Clearance Market
- By Method
- Middle East & Africa Viral Clearance Market Size & Forecast, 2016-2027
- Competitor Analysis
- Company Description
- Financial Analysis
- Key Products
- Key Management Personnel
- Contact Address
- SWOT Analysis
- Company Profile
- Merck KGaA
- Charles River Laboratories International
- Texel
- Wuxi Biologics
- Lonza Group
- Kedrion
- Vironova Biosafety
- Bsl Bioservice
- Virusure GmbH
